Skip to content

Development and evaluation of an educational - Supportive intervention to improve quality of life in adult patients with thalassemia major

Comparing effect of receiving and not receiving an educational - Supportive intervention on quality of life in adult patients with thalassemia major

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015111812460N8
Enrollment
136
Registered
2016-01-31
Start date
2016-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Thalassemia. Major Thalassemia

Interventions

Intervention 1: In the intervention group, the following measures will be done: holding educational interventions in order to improve quality of life and lifestyle. Type of intervention, intervention
Lifestyle
In the intervention group, the following measures will be done: holding educational interventions in order to improve quality of life and lifestyle. Type of intervention, intervention of the target gr
There would be no intervention in control group, therefore, the control members will receive routine educational programs from respective medical institutions including: visits by doctor of clinic, va

Sponsors

Educational vice chancellor of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: people over 18 years old diagnosed with thalassemia major; written and informed consent to participation in the study; no serious problems in physical and mental health. Exclusion criteria: younger than 18 years; the lack of consent to participate in the study; a serious problem in the physical and mental health

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Quality of life in patients with thalassemia major. Timepoint: Before and six months after the intervention. Method of measurement: Quality of life questionnaire (SF-12).

Secondary

MeasureTime frame
PRECEDE Model constructs. Timepoint: Before and six months after the intervention. Method of measurement: Questionnaire according to PRECEDE Model constructs.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roya Sadeghi

Tehran University of Medical Sciences

sadeghir@tums.ac.ir+98 21 4293 3210

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026